SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ind-Swift Laboratories informs about analyst meet

26 Feb 2026 Evaluate

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ind-Swift Laboratories has informed that One to One Investor meet with Seven Canyons Funds - Stock Pro Advisors is scheduleda on Monday, 2nd March, 2026 at 06:30 pm (after business hours). No Unpublished Price Sensitive Information is proposed to be shared by the Company during the aforesaid Analyst / Investor Meeting. This Disclosure is also made available on the website of the Company: https://www.indswiftlabs.com/investor.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Labs. Share Price

214.05 7.85 (3.81%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: